Poliscio Analytics LLC
  • Home
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
Hype and Hope: Brain-chip Progress Evokes Investigations, Controversy

Hype and Hope: Brain-chip Progress Evokes Investigations, Controversy

by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices

FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other:  Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
Hot-Button Requests at the FDA as Agency Gets Tough on Menthol Cigarettes

Hot-Button Requests at the FDA as Agency Gets Tough on Menthol Cigarettes

by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market

FOIAengine:  Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
Hot-Button Requests at the FDA as Agency Gets Tough on Menthol Cigarettes

WanaLawsuit? WanaBana.

by John A. Jenkins | Mar 13, 2024 | FDA, FOIA, Law Firms, Non-Profits, Pharmaceuticals

FOIAengine Spotlights a Non-Profit Newsroom and Another Problem for the FDA The Food and Drug Administration was already under fire from Congress and others after hundreds of toddlers in 44 states were poisoned last year by lead-tainted pouches of apple puree and...
For Elon Musk, a Trail of Legal Challenges

For Elon Musk, a Trail of Legal Challenges

by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market

FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets.  One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk.   The other – Aaron Greenspan –...
Hedge Funds Watching Drug Makers

Hedge Funds Watching Drug Makers

by Randy E. Miller | Feb 14, 2024 | FDA, FOIA, Hedge Funds, Litigation, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas.  That’s according to...
A Raft of Document Requests from the FTC and Media

A Raft of Document Requests from the FTC and Media

by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation

FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC